ABBV vs RVTY · P/E 81, rev $16.99B vs P/E 42, rev $1.44B
AbbVie Inc (ABBV) versus Revvity Inc. (RVTY) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Not investment advice. Open the ABBV and RVTY stock pages for the full models.
Not investment advice.